[Saturation index and fraction of inspired oxygen as a predictor in COVID-19].

Shareni Berenice Castro-Arellano, Laura Elizabeth Sandoval-Mosqueda, Francisco Javier Flores-Murrieta
{"title":"[Saturation index and fraction of inspired oxygen as a predictor in COVID-19].","authors":"Shareni Berenice Castro-Arellano, Laura Elizabeth Sandoval-Mosqueda, Francisco Javier Flores-Murrieta","doi":"10.5281/zenodo.8319752","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease leads to silent hypoxia, ARDS, and organ failure. The saturation and fraction of inspired oxygen have been related to the degree of lung damage, can be considered as a monitoring tool for lung function during hospitalization and a predictor of mortality in patients with pneumonia by COVID-19.</p><p><strong>Objective: </strong>To evaluate the usefulness of the oxygen saturation index and fraction of inspired oxygen as a predictor of mortality in patients with COVID-19 pneumonia.</p><p><strong>Material and methods: </strong>A retrospective, longitudinal, analytical study. Files of eligible patients with a diagnosis of SARS-CoV-2 pneumonia were admitted to HGR No.2, complete file, recording of oxygen saturation and inspired fraction of oxygen, were included. Patients dependent on supplemental oxygen, who did not require supplemental oxygen during their hospitalization, incomplete records, patients who have died from non-pulmonary causes, were excluded.</p><p><strong>Results: </strong>A sample of 175 files with a diagnosis of pneumonia with SARS-CoV-2 was obtained. A logistic regression model was performed including age over 60 years BE of 2.68, with CI (1.09-6.5), DM2 with a BE of 2.35 with CI (0.99-5.59), HTA with a BE of 0.80, with CI (0.32-2.02), SAFI index less than 310 with a BE of 6.63, with a CI (2.64-16.65), endotracheal intubation with a BE 48.43, and a CI (2.64-16.65).</p><p><strong>Conclusion: </strong>The SpO2/Fio2 index can be used for continuous monitoring of lung function in patients with COVID-19 pneumonia, in an accessible, easy and economical way. A relationship with mortality was obtained in patients with SpO2/FiO2 less than 310 associated with other factors.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10735272/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.8319752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronavirus disease leads to silent hypoxia, ARDS, and organ failure. The saturation and fraction of inspired oxygen have been related to the degree of lung damage, can be considered as a monitoring tool for lung function during hospitalization and a predictor of mortality in patients with pneumonia by COVID-19.

Objective: To evaluate the usefulness of the oxygen saturation index and fraction of inspired oxygen as a predictor of mortality in patients with COVID-19 pneumonia.

Material and methods: A retrospective, longitudinal, analytical study. Files of eligible patients with a diagnosis of SARS-CoV-2 pneumonia were admitted to HGR No.2, complete file, recording of oxygen saturation and inspired fraction of oxygen, were included. Patients dependent on supplemental oxygen, who did not require supplemental oxygen during their hospitalization, incomplete records, patients who have died from non-pulmonary causes, were excluded.

Results: A sample of 175 files with a diagnosis of pneumonia with SARS-CoV-2 was obtained. A logistic regression model was performed including age over 60 years BE of 2.68, with CI (1.09-6.5), DM2 with a BE of 2.35 with CI (0.99-5.59), HTA with a BE of 0.80, with CI (0.32-2.02), SAFI index less than 310 with a BE of 6.63, with a CI (2.64-16.65), endotracheal intubation with a BE 48.43, and a CI (2.64-16.65).

Conclusion: The SpO2/Fio2 index can be used for continuous monitoring of lung function in patients with COVID-19 pneumonia, in an accessible, easy and economical way. A relationship with mortality was obtained in patients with SpO2/FiO2 less than 310 associated with other factors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[饱和指数和吸入氧气分数作为新冠肺炎的预测因素]。
背景:冠状病毒疾病会导致无症状缺氧、ARDS和器官衰竭。吸入氧气的饱和度和分数与肺损伤的程度有关,目的:评估氧饱和度指数和吸入氧分数作为新冠肺炎肺炎患者死亡率预测指标的有效性。材料和方法:回顾性、纵向、分析性研究。诊断为严重急性呼吸系统综合征冠状病毒2型肺炎的符合条件的患者的档案被纳入HGR 2号,包括完整的档案,氧饱和度和氧吸入分数的记录。依赖补充氧气、住院期间不需要补充氧气、记录不完整、非肺部原因死亡的患者被排除在外。结果:获得了175份诊断为严重急性呼吸系统综合征冠状病毒2型肺炎的文件样本。进行逻辑回归模型,包括年龄超过60岁的BE 2.68,CI(1.09-6.5),BE 2.35的DM2,CI(0.99-5.59),BE 0.80的HTA,CI(0.32-2.02),BE 6.63的SAFI指数小于310,CI(2.64-16.65),BE 48.43的气管插管,结论:SpO2/Fio2指数可用于新冠肺炎肺炎患者肺功能的连续监测,方法简便、经济。SpO2/FiO2低于310且与其他因素相关的患者与死亡率之间存在关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Breast cancer: suspicious findings on mastography associated with the histopathological result]. [Changes in hypertensive control 2020-2021 in a family medicine unit]. [Coronary artery disease multivessel not amenable to revascularization: contemporary cohort]. [Detection of ionizing radiation in operating room and hospital areas]. [Diaphragmatic excursion time index as a predictor of extubation in intensive therapy].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1